← Open Payments lookup

EMILY GREENLEY: Open Payments

NPI 1497104814 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,160 in 74 payments from 19 companies in 2025. Trend: 2023 $1,458 · 2024 $1,400 · 2025 $1,160

Food & beverage: $1,160
CompanyPaymentsAmount
ABBVIE INC.19$301
Lilly USA, LLC10$158
Dexcom, Inc.13$139
Boehringer Ingelheim Pharmaceuticals, Inc.6$97
Eisai Inc.3$87
Sumitomo Pharma America, Inc.4$75
Otsuka America Pharmaceutical, Inc.3$52
AstraZeneca Pharmaceuticals LP2$33
Novartis Pharmaceuticals Corporation2$30
GlaxoSmithKline, LLC.2$29

Products named: VRAYLAR, MOUNJARO, Dexcom G6 Transmitter, JARDIANCE, Leqembi, GEMTESA, UBRELVY, QULIPTA.

Industry payments across MO — which companies pay providers there.